Diaz-Rubio E - Search Results

1

Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study.

Barnadas A, Mendiola C, Casado A, Villar A, Jimeno J, Clerigue M, Rosell R, Diaz-Rubio E, Cortés-Funes H, García de Paredes M. Barnadas A, et al. Eur J Cancer. 1997 Feb;33(2):312-5. doi: 10.1016/s0959-8049(96)00372-3. Eur J Cancer. 1997. PMID: 9135508 Clinical Trial.

2

Oral idarubicin in measurable gastric cancer.

Abad-Esteve A, Diaz-Rubio E, Jimeno JM, Rosell R, Villar A, Gonzalez-Larriba JL. Abad-Esteve A, et al. Am J Clin Oncol. 1989 Feb;12(1):14-6. doi: 10.1097/00000421-198902000-00004. Am J Clin Oncol. 1989. PMID: 2912018

3

Progressive loss of antiemetic efficacy during subsequent courses of chemotherapy.

Martin M, Diaz-Rubio E, Casado A, Dominguez S, Sastre J. Martin M, et al. Eur J Cancer. 1992;28(2-3):430-2. doi: 10.1016/s0959-8049(05)80069-3. Eur J Cancer. 1992. PMID: 1591058

4

Treatment of advanced colorectal cancer with recombinant interferon alpha and fluorouracil: activity in liver metastasis.

Díaz Rubio E, Jimeno J, Camps C, Aranda E, Massuti B, Blanco E, Antón A, Lízón J, González Larriba JL. Díaz Rubio E, et al. Cancer Invest. 1992;10(4):259-64. doi: 10.3109/07357909209032749. Cancer Invest. 1992. PMID: 1628224

5

Phase II study of carboplatin in advanced breast cancer: preliminary results.

Martin M, Diaz-Rubio E, Casado A, López Vega JM. Martin M, et al. Semin Oncol. 1991 Feb;18(1 Suppl 2):23-7. Semin Oncol. 1991. PMID: 1992532 Clinical Trial.

6

Phase I study of mitonafide with a 3-day administration schedule: early interruption due to severe central nervous system toxicity.

Díaz-Rubio E, Martín M, López-Vega JM, Casado A, Benavides A. Díaz-Rubio E, et al. Invest New Drugs. 1994;12(4):277-81. doi: 10.1007/BF00873041. Invest New Drugs. 1994. PMID: 7775127 Clinical Trial.

7

Preliminary results of a phase II trial of chronic oral etoposide in breast cancer.

Martín M, Casado A, Lluch A, Adrover E, Diaz-Rubio E, García-Conde J. Martín M, et al. Cancer Treat Rev. 1993;19 Suppl C:47-52. doi: 10.1016/0305-7372(93)90047-u. Cancer Treat Rev. 1993. PMID: 8221716 Clinical Trial.

8

Phase II study of mitonafide in non-small cell lung cancer (NSCLC).

Casado A, Rosell R, García-Gómez R, Díaz-Rubio E, Pérez-Manga G, Font A, Benavides A, Martín M. Casado A, et al. Invest New Drugs. 1996;14(4):415-7. doi: 10.1007/BF00180820. Invest New Drugs. 1996. PMID: 9157079 Clinical Trial.

9

Paclitaxel plus vinorelbine in metastatic breast Ca patients with contraindications to receive anthracyclines.

Martin M, Casado A, Perez Segura P, Garcia Carbonero I, Diaz-Rubio E. Martin M, et al. Oncology (Williston Park). 1998 Jan;12(1 Suppl 1):28-30. Oncology (Williston Park). 1998. PMID: 9516600 Free article.

10

Weekly continuous infusion of 5-fluorouracil with oral leucovorin in metastatic breast cancer patients with primary resistance to doxorubicin.

Nieto Y, Martín M, Alonso JL, Casado A, Ayala F, López-Martín JA, Rodríguez-Lescure A, Díaz-Rubio E. Nieto Y, et al. Breast Cancer Res Treat. 1998 Jul;50(2):167-74. doi: 10.1023/a:1006062018355. Breast Cancer Res Treat. 1998. PMID: 9822221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters